International Symposium on Immune Diversity and Cancer Therapy Kobe2017
Sponsored by Kobe Biomedical Innovation Cluster
Cosponsored by Kobe city
Date: Jan 26-28, 2017
Place: Kobe Portopia Hotel
Organizers
Yo-ichi Nabeshima (Chair)
Masanori Fukushima
Tasuku Honjo
Maki Kobayashi (Secretary General)
Speakers:
Part1 PD-1 and Cancer TherapyDr. Rafi Ahmed (Emory University)
Dr. Sidonia Fagarasan (RIKEN Center for Integrative Medical Sciences)
Dr. Thomas Gajewski (University of Chicago)
Dr. Nils Lonberg (Bristol-Myers Squibb)
Dr. Hiroyoshi Nishikawa (National Institute of Cancer Research)
Dr. Hiroshi Shiku (Mie University)
Part2 Cancer and Mutations
Dr. Peter Campbell (Wellcome Trust Sanger Institute)
Dr. Ricaldo Dalla-Favera (Columbia University)
Dr. Yusaku Nakabeppu (Kyushu University)
Dr. Tomoo Ogi (Nagoya University)
Dr. Robert Schreiber (Washington University School of Medicine)
Dr. Atushiro Shibata (National Institute of Cancer Research)
Dr. Bernard Weissman (University of North Carolina)
Part3 AID and Genome Instability
Dr. Qiang Pan Hammarstrom (Karolinska Institute)
Dr. Nayun Kim (University of Texas)
Dr. Masamichi Muramatsu (Kanazawa University)
Dr. Markus Muschen (University of California, San Francisco)
Dr. Nina Papavasilliou (Rockfeller University)
Dr. Yves Pommier (National Cancer Institute)